Denali Therapeutics
Peter Klein joined the Board of Directors as an independent director. Mr. Klein has 25 years of experience as a senior finance executive. He served as Chief Financial Officer of Microsoft Corporation from November 2009 until May 2013 and spent over 11 years at Microsoft. Most recently, he served as Chief Financial Officer of WME, a global leader in sports and entertainment marketing, from January 2014 until June 2014.
Peter holds a B.A. from Yale University and an M.B.A from University of Washington. He also serves on the board of directors of Apptio Inc. and F5 Networks, Inc., both publicly traded companies.
This person is not in the org chart
This person is not in any offices
Denali Therapeutics
6 followers
Denali Therapeutics is dedicated to defeating neurodegenerative diseases by breaking through historical barriers in scientific research and clinical development in order to deliver safe and effective medicines to patients and families.